Fri, Jan 24, 2020 · 17:00

As the incidence of melanoma continues to rise rapidly in the United States and around the world, the need to educate clinicians from various specialties on the disease also increases. During this course nationally recognized experts will present information on prevention, risk assessment, early detection, genetic factors, and current and future treatment choices for melanoma patients. Issues concerning surgical management, adjuvant therapy, advanced disease therapy, and personalizing the course of treatment for individual patients will also be discussed. This course is designed to provide information that will help clinicians in their decision making regarding these difficult patient problems. The course will be taught by a wide range of experts as this most serious of skin cancers will require multidisciplinary efforts to conquer.

Prices:
Physicians (MD, DO): USD 375.0
Non-physician: USD 275.0

Speakers: James W. Patterson, MD, Cora S. Humberson, MD, Travis W. Blalock, MD, Ashley Wysong, MD, MS , Caroline D. Piggott, MD, Benjamin F. Kelley, MD, Merrick I. Ross, MD, Geva E. Mannor, MD, MPH, Chritopher M. Bergeron, MD , Prabhakar Tripuraneni, MD, Frederick S. Fish, III, MD, Reverend Jack W. Baca, Kathryn B. Bollin, MD, Kathleen M. Murphy, PhD, Robert A. Cosgrove, ESQ, Hugh T. Greenway, Jr., MD, FAAD